TP53 and myelodysplastic syndrome: The same circumstance was highlighted in the last study of the TP53 allelic state implications on MDS prognostication [55] In a cohort of 3324 patients, it was shown that the two TP53 allelic states were associated with distinct clinical presentations and outcomes.